Neuromodulation Options and Patient Selection for Parkinson's Disease.

Area of Science:

• Neurology
• Neurosurgery

Background:

• Deep brain stimulation (DBS) and pump therapies are established treatments for advanced Parkinson's disease (PD) with motor complications.
• Medical management alone is often insufficient for controlling symptoms in advanced PD.

Purpose of the Study:

• To review current neuromodulation strategies for Parkinson's disease.
• To emphasize patient selection and decision-making among therapeutic options.

Main Methods:

• Overview of established and novel neuromodulation therapies for PD.
• Discussion of criteria for patient selection.
• Emphasis on multidisciplinary evaluation and technical expertise.

Main Results:

• Neuromodulation offers various treatment modalities for advanced PD.
• Novel therapies include intrajejunal levodopa infusions (IJLI), continuous subcutaneous apomorphine infusions (CSAI), and MR-guided Focused Ultrasound (MRgFUS).
• Successful outcomes depend on careful patient selection, multidisciplinary assessment, and technical skill.

Conclusions:

• Neuromodulation strategies are vital for managing advanced Parkinson's disease.
• Choosing the appropriate therapy requires careful consideration of individual patient factors.
• Optimizing treatment requires a comprehensive approach involving patient selection and expertise.